QXO slides as investors weigh dilution and leverage tied to $17B TopBuild deal

QXO, Inc. (QXO) is down 8.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to QXO’s announced agreement to acquire TopBuild in a large cash-and-stock transaction. Even when a deal is strategically positive, QXO shares can fall on concerns about share issuance (dilution), added leverage, and execution risk while the transaction works through approvals and closing.

Details:

QXO announced a definitive agreement to acquire TopBuild in a transaction valued at about $17 billion, with the deal expected to close in Q3 2026 (subject to shareholder and regulatory approvals).

TopBuild shareholders can elect either cash or QXO stock (with elections subject to transaction-level proration limits), implying QXO will issue a meaningful amount of new equity if stock is chosen broadly.

Transaction materials describe a funding mix that includes new stock issuance, preferred-stock financing, and new debt, which can pressure the acquirer’s shares due to dilution and balance-sheet risk.

The related Form 8-K and presentation outline targeted synergies over multiple years, which can heighten near-term uncertainty until integration progress becomes visible.

Sources:

QXO Investor Relations, U.S. Securities and Exchange Commission, Axios

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive QXO Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$QXO Hedge Fund Activity

We have seen 325 institutional investors add shares of $QXO stock to their portfolio, and 183 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BAILLIE GIFFORD & CO added 14,644,305 shares (+16117.6%) to their portfolio in Q4 2025, for an estimated $282,488,643
MORGAN STANLEY added 13,803,846 shares (+25.9%) to their portfolio in Q4 2025, for an estimated $266,276,189
MFN PARTNERS MANAGEMENT, LP removed 7,973,524 shares (-20.8%) from their portfolio in Q4 2025, for an estimated $153,809,277
NORGES BANK added 7,279,467 shares (+inf%) to their portfolio in Q4 2025, for an estimated $140,420,918
FRED ALGER MANAGEMENT, LLC added 6,844,574 shares (+75.4%) to their portfolio in Q4 2025, for an estimated $132,031,832
MADRONE ADVISORS, LLC removed 4,426,196 shares (-46.4%) from their portfolio in Q4 2025, for an estimated $85,381,320
SOUND SHORE MANAGEMENT INC /CT/ added 4,002,028 shares (+inf%) to their portfolio in Q4 2025, for an estimated $77,199,120

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$QXO Analyst Ratings

Wall Street analysts have issued reports on $QXO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Citigroup issued a "Buy" rating on 01/08/2026
Truist Securities issued a "Buy" rating on 12/19/2025
Loop Capital issued a "Buy" rating on 12/12/2025

To track analyst ratings and price targets for $QXO, check out Quiver Quantitative's $QXO forecast page.

$QXO Price Targets

Multiple analysts have issued price targets for $QXO recently. We have seen 6 analysts offer price targets for $QXO in the last 6 months, with a median target of $30.5.

Here are some recent targets:

Jeffrey Hammond from Keybanc set a target price of $32.0 on 04/20/2026
Mike Dahl from RBC Capital set a target price of $28.0 on 04/06/2026
Scott Schneeberger from Oppenheimer set a target price of $30.0 on 01/16/2026
Anthony Pettinari from Citigroup set a target price of $31.0 on 01/08/2026
Keith Hughes from Truist Securities set a target price of $26.0 on 12/19/2025
Garik Shmois from Loop Capital set a target price of $31.0 on 12/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.